The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs

被引:23
|
作者
Lubinski, Jan [1 ]
Huzarski, Tomasz
Kurzawski, Grzegorz
Suchy, Janina
Masojc, Bartlomiej
Mierzejewski, Marek
Lener, Marcin [2 ]
Domagala, Wenancjusz
Chosia, Maria
Teodorczyk, Urszula
Medrek, Krzysztof
Debniak, Tadeusz
Zlowocka, Elzbieta
Gronwald, Jacek
Byrski, Tomasz
Grabowska, Ewa [2 ]
Nej, Katarzyna [2 ]
Szymanska, Anna
Szymanska, Jolanta
Matyjasik, Joanna
Cybulski, Cezary
Jakubowska, Anna
Gorski, Bohdan
Narod, Steven A. [3 ]
机构
[1] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, PL-70115 Szczecin, Poland
[2] Univ Szczecin, Interuniv Unit Mol Biol, Szczecin, Poland
[3] Univ Toronto, Ctr Res Womens Hlth, Toronto, ON M5S 1A1, Canada
关键词
NOD2; cancer susceptibility; multiple organs;
D O I
10.1186/1897-4287-3-2-59
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The NOD2 gene has been associated with susceptibility to Crohn's disease and individuals with Crohn's disease are at increased risk for cancer at a number of organ sites. We studied the association between the 3020insC allele of the NOD2 gene and cancer among 2604 cancer patients and 1910 controls from Poland. Patients were diagnosed with one of twelve types of cancer in the Szczecin region between 1994 and 2004. Significant associations were found for colon cancer (OR=1.8; 95% CI 1.2 to 2.6), for lung cancer (OR=1.7; 95% CI=1.1 to 2.5) and for ovarian cancer (OR=1.6; 95% CI 1.1 to 2.3). In addition, a significant association was found for early-onset laryngeal cancer (OR=2.9; 95% CI 1.4 to 6.2) and for breast cancer in the presence of DCIS (OR=2.1 95% CI=1.2 to 3.6). The NOD2 3020insC allele is relatively common (in Poland 7.3% of individuals) and may be responsible for an important fraction of cancer cases. We estimate that the lifetime cancer risk among carriers of this allele is 30% higher than that of individuals with two wild-type alleles.
引用
收藏
页码:59 / 63
页数:5
相关论文
共 50 条
  • [21] The Crohn's associated NOD2 3020InsC frameshift mutation does not confer susceptibility to ankylosing spondylitis
    D'Amato, M
    Sorrentino, R
    Pettersson, S
    [J]. JOURNAL OF RHEUMATOLOGY, 2002, 29 (11) : 2470 - 2471
  • [22] NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Hart nationality
    Qiu-Sha Guo Bing Xia Yi Jiang Yan Qü Jing Li Department of Internal Medicine
    [J]. World Journal of Gastroenterology, 2004, (07) : 1069 - 1071
  • [23] The NOD2/CARD15 3020insC polymorphism is not associated with gastrointestinal disease in autistic patients.
    Lynch, A.
    Ring, M.
    Sheils, O.
    Martin, C. M.
    O'Leary, J. J.
    [J]. JOURNAL OF PATHOLOGY, 2006, 210 : 13 - 13
  • [24] The NOD2 3020insC mutation in women with breast cancer from the Bydgoszcz Region in Poland. First results
    Janiszewska H.
    Haus O.
    Lauda-Świeciak A.
    Ba̧k A.
    Mierzwa T.
    Sir J.
    Laskowski R.
    [J]. Hereditary Cancer in Clinical Practice, 4 (1) : 15 - 19
  • [25] 3020insC mutation within the NOD2 gene in Crohn's disease: frequency and association with clinical pattern in an Italian population
    Vavassori, P
    Borgiani, P
    D'Apice, MR
    De Nigris, F
    Blanco, GD
    Monteleone, I
    Biancone, L
    Novelli, G
    Pallone, F
    [J]. DIGESTIVE AND LIVER DISEASE, 2002, 34 (02) : 153 - 153
  • [26] THE PRESENCE OF SNP13 3020INSC NOD2/CARD15 IS ASSOCIATED WITH CROHN DISEASE IN POLISH CHILDREN
    Kierkus, J.
    Dadalski, M.
    Buning, C.
    Socha, P.
    Schmidt, H.
    Ryzko, J.
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 : E100 - E100
  • [27] Genetic and environmental influence on gastrointestinal barrier function in Crohn's disease: Relevance of NOD2 (3020insC) mutation.
    Buehner, S
    Herrmann, D
    Krueger, S
    Genschel, J
    Baier, P
    Schmidt, H
    Lochs, H
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A266 - A266
  • [28] Crohn's disease patients homozygous for the 3020insC NOD2 mutation have a defective NOD2/TLR4 cross-tolerance to intestinal stimuli
    Kullberg, Bart Jan
    Ferwerda, Gerben
    de Jong, Dirk J.
    Drenth, Joost P. H.
    Joosten, Leo A. B.
    Van der Meer, Jos W. M.
    Netea, Mihai G.
    [J]. IMMUNOLOGY, 2008, 123 (04) : 600 - 605
  • [29] Crohn's disease-associated NOD2(3020insC) mutant is a novel regulator of IL-10 gene expression
    Ma, Xiaojing
    Homma, Yoichiro
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 : S225 - S225
  • [30] Impaired immune recognition of M. tuberculosis and M. paratuberculosis in Crohn patients homozygous for the NOD2 3020insC mutation
    Ferwerda, G.
    de Jong, D. J.
    van Crevel, R.
    Ottenhoff, T. H. M.
    van der Meer, J. W. M.
    Kullberg, B. J.
    Netea, M. G.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (10) : A48 - A49